Company intelligence / Profile preview

Cardiosolutions

West Bridgewater, Massachusetts, United States

Ownership: Private
Development stage: Other

Overview

Cardiosolutions is developing a minimally invasive, percutaneous device (Mitra-Spacer) and catheter delivery system for the treatment of moderate to severe mitral regurgitation, with ongoing product development and early-stage clinical evaluation; no peer-reviewed published clinical trial results yet available.

Therapeutic areas: Cardiovascular
Modalities: Device
Industry: Implantable Medical Devices

Partnerships

Sorin Group

Beyond the preview

Go deeper on Cardiosolutions.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cardiosolutions.

Explore the full profile